Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186841 Ligand activated transcriptional regulator proteins
10/02/2003US20030186405 Micro/nano-embossing process and useful applications thereof
10/02/2003US20030186392 Biopolymer thickener
10/02/2003US20030186271 Pharmaceutical compositions in particulate form
10/02/2003US20030186191 Dispensing apparatus and cartridge
10/02/2003US20030185918 First ingredient obtainable from turmeric; a second ingredient obtainable from ginger; and a third ingredient obtainable from horseradish; treating viral infections
10/02/2003US20030185912 Anti-microbial compositions and methods of using same
10/02/2003US20030185909 Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
10/02/2003US20030185907 Method for treatment of inflammation and pain in mammals
10/02/2003US20030185905 Plant extracts for the treatment of increased bone resorption
10/02/2003US20030185901 Methods of treating conditions with a metal-containing material
10/02/2003US20030185896 Polymer particles include pores such that the predominant size of pores near the center of the particles is greater than the predominant size of pores adjacent to periphery of the particle
10/02/2003US20030185895 Spherical polymer particle (e.g., a polyvinyl acetal) having an internal reservoir region including large pores containing therapeutic agent and a metering region having fewer relatively large pores.
10/02/2003US20030185894 Process for producing nanoparticles of paclitaxel and albumin
10/02/2003US20030185893 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
10/02/2003US20030185892 Intraocular delivery compositions and methods
10/02/2003US20030185891 Glycogen phosphorylase inhibitor
10/02/2003US20030185888 Volume efficient controlled release dosage form
10/02/2003US20030185887 Controlled release oral dosage form of beta-adrenergic blocking agents
10/02/2003US20030185886 Process for the preparation of rapidly disintegrating tablet
10/02/2003US20030185885 Non-granulated levothyroxine pharmaceutical compositions
10/02/2003US20030185884 Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine
10/02/2003US20030185882 Pharmaceutical compositions containing oxybutynin
10/02/2003US20030185881 Having an enclosing wall comprising a thermoplastic film of foamed modified cellulose material, preferably hydroxypropyl methyl cellulose.
10/02/2003US20030185880 Glyburidge composition
10/02/2003US20030185879 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
10/02/2003US20030185878 Process for producing phospholipid-containing drug
10/02/2003US20030185877 Method of producing oily suspensions of water-soluble vitamins
10/02/2003US20030185875 Sustained or controlled drug release
10/02/2003US20030185873 Provides reversible local anesthesia when implanted or injected in a patient, and a non-glucocorticoid augmenting agent effective to prolong the duration of the local anesthesia
10/02/2003US20030185869 Having lysozyme adsorbed onto or associated with the surface of an active agent
10/02/2003US20030185863 Linear poly-alpha-1,4-glucan and a swelling agent with or without starch; producing capsules or controlled-release systems.
10/02/2003US20030185861 Containing a fatty acid triglyceride and one or more C14-18 fatty acid glycerides
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185840 Induction of tumor immunity by variants of folate binding protein
10/02/2003US20030185816 Modified immunogenic self-protein and a surfactant capable of acting as a solubiliser, especially modified human TNF alpha and cetylpyridinium chloride
10/02/2003US20030185794 Such as a pleiotrophin or midkine molecule in a pharmaceutically acceptable carrier.
10/02/2003US20030185772 Alleviates skin irritation by blending in polypropylene glycol, a specific polar oil, or polybutylene glycol, as well as an ultraviolet absorbent.
10/02/2003US20030185768 Method of treating periodontal disease
10/02/2003US20030185766 HFA suspension formulations of an anhydrate
10/02/2003US20030185765 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid
10/02/2003US20030185764 i) a fraction of fine particle size constituted by a mixture of physiologically acceptable excipient and an additive; ii) a fraction of coarse particles; and iii) at least one active ingredient; treating asthma
10/02/2003US20030185763 Containing water, a drug and a mixture of microcrystalline cellulose and an alkali metal carboxyalkylcellulose
10/02/2003US20030185762 Aerosol is produced by an electrohydrodynamic spraying device; aqueous carrier vehicle
10/02/2003US20030185761 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/02/2003US20030185758 Embolizing a blood vessel by injecting a mixture os polyacrylonitrile, polyvinyl acetate, cellulose acetate butyrate, nitrocellulose, polycarbonate urethane or maleic acid-styrene copolymer; contrast agent and solvent
10/02/2003US20030185757 Iron-containing core, a primary coat (synthesis polymer) which is responsible for optimal sized nanoparticles, and a secondary coat (targeting polymer)
10/02/2003US20030185752 Liquid polymer comprising the reaction product of a polybasic acid or derivative thereof, a fatty acid, and a polyol; having a melting point less than about 40 degrees C.
10/02/2003US20030185704 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
10/02/2003US20030183962 Forming beads of a predetermined size from a starting material which is a template polymer or ice; contacting the beads with a structural polymer; crosslinking the structural polymer
10/02/2003US20030183228 Aerosolized active agent delivery
10/02/2003US20030183224 Metered dose inhaler
10/02/2003US20030183223 Metered dose inhaler
10/02/2003CA2484044A1 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003CA2480683A1 Assembled unit consisting of individually separable transdermal therapeutic systems
10/02/2003CA2480417A1 Diclofenac sodium oral pharmaceutical
10/02/2003CA2480343A1 Medical treatment system and production method therefor
10/02/2003CA2480334A1 Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytochrome p-450
10/02/2003CA2480007A1 Topical composition based on ion-exchange resins, in particular for treating erythemas
10/02/2003CA2480005A1 Heat-reversible composition treating hyposalia and asialia
10/02/2003CA2479748A1 Fine particle size pioglitazone
10/02/2003CA2479718A1 Analgesics for nasal administration
10/02/2003CA2479686A1 A composition for treating pollinosis comprising an extract of sasa albo-marginata
10/02/2003CA2479383A1 Storage stable eplerenone formulation
10/02/2003CA2479260A1 Use of sulfoalkyl ether cyclodextrin as a preservative
10/02/2003CA2479252A1 Sustained release formulation of tramadol
10/02/2003CA2479214A1 A substance with sedative effect
10/02/2003CA2478974A1 Inhalable sustained therapeutic formulations
10/02/2003CA2478801A1 Method for administration of growth hormone via pulmonary delivery
10/02/2003CA2478629A1 Method and apparatus for producing dry particles
10/02/2003CA2478327A1 Hgh (human growth hormone) formulations for pulmonary administration
10/02/2003CA2476327A1 Method of administering an injectable antibiotic to the ear of an animal
10/01/2003EP1348460A2 Creating an aerosolized formulation of insulin
10/01/2003EP1348451A1 Compositions and medical devices utilizing bioabsorbable liquid polymers
10/01/2003EP1348436A1 Meloxicam suppositories
10/01/2003EP1348432A1 Cyclodextrin-containing pharmaceutical preparation
10/01/2003EP1348431A1 Process for producing nanoparticles of paclitaxel and albumin
10/01/2003EP1348430A1 Improved paclitaxel-based antitumor formulation
10/01/2003EP1348429A2 Melt-extruded orally administrable opioid formulations
10/01/2003EP1348428A1 Powdery preparations and proecss for producing the same
10/01/2003EP1348427A1 Ophthalmic compositions containing galactomannan polymers and borate
10/01/2003EP1348425A1 Hydrogel adhesives for use on hair or fiber-populated surfaces
10/01/2003EP1347980A1 Compounds specific to adenosine-a1,-a2a, and- a3-receptor and uses thereof
10/01/2003EP1347964A2 Tetraether lipid derivatives and liposomes containing tetraether lipid derivatives and lipid agglomerates and the use thereof
10/01/2003EP1347789A2 Hot melt adhesives for dermal application
10/01/2003EP1347787A1 Procedure and composition of treatment and/or care of the eye
10/01/2003EP1347781A1 Oral pharmaceutical compositions containing cyclodextrins as taste masking agent
10/01/2003EP1347780A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
10/01/2003EP1347770A2 Method of making a protein polymer and uses of the polymer
10/01/2003EP1347767A1 Tahitian noni juice on cox-1 and cox-2 and tahitian noni juice as a selective cox-2 inhibitor
10/01/2003EP1347765A2 Dermatological formulations
10/01/2003EP1347764A2 Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism
10/01/2003EP1347760A2 Nmda receptor agonist pharmaceutical compositions
10/01/2003EP1347756A2 Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart
10/01/2003EP1347753A1 Topical composition and method for treating urinary stress incontinence
10/01/2003EP1347749A2 Transdermal therapeutic system comprising the active ingredient oxybutynin
10/01/2003EP1347748A2 Hydrostatic delivery system for controlled delivery of agent
10/01/2003EP1347747A2 Method for preparing submicron particle suspensions
10/01/2003EP1347746A1 Over-coated chewing gum formulations including tableted center
1 ... 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 ... 2991